Industry Insights
-
Validating A Better ALS Biomarker With Coya’s Fred Grossman
4/24/2024
Coya Therapeutics President and CMO Fred Grossman, DO, FAPA discusses a potential new biomarker for ALS — 4-HNE, an oxidative stress biomarker — and how it could be more effective than the current standard, NfL.
-
Will Today’s Clinical Trial Trends Become Tomorrow’s Routine?
4/23/2024
Clinical trial trends can be divided into two groups — those related to changes in the conduct of clinical trials and those related to the changes in therapeutic areas. Will these trends hold steady as 2024 unfolds?
-
Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch
4/22/2024
The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.
-
Backup Sites: The Closers Of Clinical Trials
4/22/2024
With the rising complexity of trials and dwindling site availability, the adoption of backup sites has become increasingly commonplace, reflecting the industry's commitment to maximizing recruitment potential.
-
Diversity In Clinical Trials: Walking The Walk
4/22/2024
Discover why achieving true diversity demands more than rhetoric—requiring genuine engagement, cultural humility, and a commitment to understanding and addressing the unique needs of marginalized communities.
-
Yes, Women’s Exclusion In Clinical Trials Is Still A Problem
4/22/2024
Despite the progress made in including women in clinical trials, challenges persist. Hera Biotech CEO Somer Baburek explains why the fight for inclusion isn't over.
-
Bringing Clinical Research To The Patient Using Patient-Centric Tech
4/19/2024
By fostering daily interactions between patients and technology, these smart hubs offer a sustainable approach to ensuring the success and integrity of clinical trials in an evolving landscape of drug development.
-
Why In The World Should You Come to San Diego?
4/19/2024
With over 180 sessions across 13 tracks and nine engaging learning formats, attendees will delve into emerging fields such as precision medicine, regulatory CMC, and product quality, and value-based access.
-
Considering The Patient Experience Is Critical To Creating A Successful ICF
4/19/2024
If an ICF is not written with the patient in mind — so that it truly facilitates an informed consent — a clinical trial runs the risk of losing viable study participants and derailing study start-up, even success.
-
When Quickbooks Leaves Your Life Sciences Venture Struggling
4/18/2024
Is QuickBooks keeping pace with your life sciences venture? Learn the signs it's time to move beyond and adopt tailored solutions for growth, compliance, collaboration, security, and automation.